QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)

ADMA Biologics (ADMA) Earnings Date, Estimates & Call Transcripts

$5.52
+0.12 (+2.22%)
(As of 02/27/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ADMA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADMA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ADMA Biologics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.04$0.04$0.04 
Q2 20241$0.05$0.05$0.05 
Q3 20241$0.06$0.06$0.06 
Q4 20241$0.07$0.07$0.07 
FY 20244$0.22$0.22 $0.22

ADMA Earnings Date and Information

ADMA Biologics has confirmed that its next quarterly earnings report will be published on Wednesday, February 28th, 2024. ADMA Biologics will be holding an earnings conference call on Wednesday, February 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

ADMA Biologics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/28/2024
Confirmed)
-------  
11/8/2023Q3 2023($0.01)($0.01)-$0.01$62.13 million$67.30 million    
8/9/2023Q2 2023($0.02)($0.02)-($0.01)$55.45 million$60.12 million    
5/10/2023Q1 2023($0.05)($0.03)+$0.02($0.03)$51.35 million$56.91 million
3/23/2023Q4 2022($0.06)($0.06)-($0.06)$49.02 million$49.98 million    
11/9/2022Q3 2022($0.08)($0.08)-($0.08)$34.57 million$41.09 million
8/10/2022Q2 2022($0.09)($0.07)+$0.02($0.07)$31.17 million$33.91 million    
5/11/2022Q1 2022($0.08)($0.10)($0.02)($0.07)$26.50 million$29.10 million    
3/24/2022Q4 2021($0.10)($0.09)+$0.01($0.09)$26.00 million$26.38 million  
11/10/2021Q3 2021($0.14)($0.13)+$0.01($0.13)$18.58 million$20.68 million    
8/10/2021Q2 2021($0.15)($0.14)+$0.01($0.15)$16.55 million$17.83 million    
5/11/2021Q1 2021($0.17)($0.16)+$0.01($0.16)$15.63 million$16.05 million  
3/24/2021Q4 2020($0.17)($0.20)($0.03)($0.20)$13.90 million$13.96 million  












ADMA Biologics Earnings - Frequently Asked Questions

When is ADMA Biologics's earnings date?

ADMA Biologics has confirmed that its next quarterly earnings data will be published on Wednesday, February 28th, 2024. Learn more on ADMA's earnings history.

How much revenue does ADMA Biologics generate each year?

ADMA Biologics (NASDAQ:ADMA) has a recorded annual revenue of $154.08 million.

How much profit does ADMA Biologics generate each year?

ADMA Biologics (NASDAQ:ADMA) has a recorded net income of -$65.90 million. ADMA has generated -$0.11 earnings per share over the last four quarters.

What is ADMA Biologics's EPS forecast for next year?

ADMA Biologics's earnings are expected to grow from ($0.02) per share to $0.22 per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ADMA) was last updated on 2/27/2024 by MarketBeat.com Staff